Literature DB >> 4645131

Serum estradiol in women ingesting combination oral contraceptive steroids.

D R Mishell, I H Thorneycroft, R M Nakamura, Y Nagata, S C Stone.   

Abstract

Entities:  

Keywords:  Action Research; Biology; Central Nervous System Effects; Endocrine System; Gonadotropins; Hormones; Mestranol; Norethindrone; Oral Contraceptives; Ovary; Physiology

Mesh：

Substances：

Year:  1972        PMID： 4645131     DOI： 10.1016/0002-9378(72)90098-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  22 in total

1.  Estrogen status and heredity are major determinants of premenopausal bone mass.

Authors:  R Armamento-Villareal; D T Villareal; L V Avioli; R Civitelli
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Changed levels of endogenous sex steroids in women on oral contraceptives.

Authors:  J M Kjeld; C M Puah; G F Joplin
Journal:  Br Med J       Date:  1976-12-04

3.  Oral contraceptive use and fracture risk around the menopausal transition.

Authors:  Delia Scholes; Andrea Z LaCroix; Rebecca A Hubbard; Laura E Ichikawa; Leslie Spangler; Belinda H Operskalski; Nancy Gell; Susan M Ott
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

4.  Targeting progesterone signaling prevents metastatic ovarian cancer.

Authors:  Olga Kim; Eun Young Park; Sun Young Kwon; Sojin Shin; Robert E Emerson; Yong-Hyun Shin; Francesco J DeMayo; John P Lydon; Donna M Coffey; Shannon M Hawkins; Lawrence A Quilliam; Dong-Joo Cheon; Facundo M Fernández; Kenneth P Nephew; Adam R Karpf; Martin Widschwendter; Anil K Sood; Robert C Bast; Andrew K Godwin; Kathy D Miller; Chi-Heum Cho; Jaeyeon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-01       Impact factor: 11.205

Review 5.  COVID-19 in Africa: an ovarian victory?

Authors:  Osman A Dufailu; Afrakoma Afriyie-Asante; Bernard Gyan; David Adu Kwabena; Helena Yeboah; Frank Ntiakoh; Meshach Asare-Werehene
Journal:  J Ovarian Res       Date:  2021-05-21       Impact factor: 4.234

Review 6.  Estrogen status and bone mass in the premenopausal period: is osteoporosis a developmental disease?

Authors:  R Civitelli; D T Villareal; R Armamento-Villareal
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

7.  The effect of previous oral contraceptive use on bone mineral density in perimenopausal women.

Authors:  M Tuppurainen; H Kröger; S Saarikoski; R Honkanen; E Alhava
Journal:  Osteoporos Int       Date:  1994-03       Impact factor: 4.507

8.  Oral contraceptive use and bone density in adolescent and young adult women.

Authors:  Delia Scholes; Laura Ichikawa; Andrea Z LaCroix; Leslie Spangler; Jeannette M Beasley; Susan Reed; Susan M Ott
Journal:  Contraception       Date:  2010-01       Impact factor: 3.375

9.  Determining the subjective and physiological effects of BZP on human females.

Authors:  Joanne C Lin; Nisha Bangs; Heeseung Lee; Rob R Kydd; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2009-09-24       Impact factor: 4.530

10.  Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.

Authors:  Francesmary Modugno; Zhuxuan Fu; Susan J Jordan; Aocs Group; Jenny Chang-Claude; Renée T Fortner; Marc T Goodman; Kirsten B Moysich; Joellen M Schildkraut; Andrew Berchuck; Elisa V Bandera; Bo Qin; Rebecca Sutphen; John R McLaughlin; Usha Menon; Susan J Ramus; Simon A Gayther; Aleksandra Gentry-Maharaj; Chloe Karpinskyj; Celeste L Pearce; Anna H Wu; Harvey A Risch; Penelope M Webb
Journal:  Eur J Epidemiol       Date:  2020-09-21       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.